Lexicon Pharmaceuticals

This article needs additional citations for verification.
Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (September 2007)

Lexicon Pharmaceuticals

	Public (NASDAQ: LXRX)
Founded	The Woodlands, TX, 1995
Headquarters	The Woodlands, Princeton, New Jersey , USA
Key people	Arthur T. Sands, CEO Alan J. Main, VP
Industry	Health Care
Employees	600 (2007)
Slogan	Discovering Breakthrough Treatments For Human Disease
Website	www.lexpharma.com

Lexicon Genetics is a medium sized biopharmaceuticals company that started operation in 1995 in The Woodlands, Texas. Lexicon genetics changed it's name in 2007 to Lexicon Pharmaceuticals (Nasdaq LXRX) to showcase itself as a full blown biotech company. The company started during the biotech bubble days as a small startup, based on its patented mouse knockout technology.In June, 2003 Lexicon Genetics purchased a privately owned small chemical library synthesis company, Coelacanth Corporation in Princeton, New Jersey^[1] and renamed the newly acquired company as Lexicon Pharmaceuticals Inc. Since 2001, Lexicon's drug discovery program harmoniously operated between biology division (situated in The Woodlands) and medicinal chemistry (in Princeton).